SPERO THERAPEUTICS INC (SPRO)

US84833T1034 - Common Stock

1.08  -0.02 (-1.82%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
106.45M103.78M53.51M18.26M9.33M
Minority Interest Expense
N/AN/AN/AN/AN/A
Operating Expenses
107.56M76.99M84.08M106.23M88.44M
Research and Development
84.48M51.44M47.59M64.53M67.00M
Selling, General, and Administrative Expenses
23.08M25.55M36.48M41.70M21.44M
Operating Income
-1.10M26.79M-30.57M-87.97M-79.11M
Interest Income/Expense
4.75M3.94M-580.00K-1.39M400.00K
Other Income/Expense
-36.00K-14.00K-60.00K-400.00K430.00K
Non Recurring Items
N/A-5.31M-15.21MN/AN/A
Income Before Taxes
3.61M25.40M-46.42M-89.76M-78.28M
Income Tax
N/A2.60MN/AN/A0.00
Net Income
3.51M22.81M-46.42M-89.76M-78.83M
EBITDA
N/A27.15M-29.70M-87.32M-78.35M
 
Per Share Data
EPS Diluted Total Ops
0.060.43-1.23-2.91-3.52
Non GAAP EPS
0.070.52-1.66-2.89-3.58
 
Statistics
Profit Margin
3.30%21.98%-86.75%-491.57%-844.91%
Operating Profit Margin
-1.04%25.81%-57.13%-481.76%-847.91%

All data in USD

Charts